Periprocedural drug therapy in carotid artery stenting: The need for more evidence

Vascular

Volumn 16, Issue 6, 2008, Pages 303-309

  Gortler, David ^a   Schlösser, Felix J V ^a   Muhs, Bart E ^a   Nelson, Michael A ^c   Dardik, Alan ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Anticoagulants; Antiplatelet therapy; Carotid artery stenting; Carotid endarterectomy; Cholesterol; Pharmacology

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ATROPINE; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLEEDING; BRADYCARDIA; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG SELECTIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROINTESTINAL TOXICITY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; STENT; STROKE; THROMBOCYTE AGGREGATION INHIBITION; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ANTICOAGULANTS; ASPIRIN; ATROPINE; CAROTID ARTERIES; CAROTID STENOSIS; HEPARIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PLATELET AGGREGATION INHIBITORS; PREMEDICATION; STENTS; TICLOPIDINE; WARFARIN;

EID: 65549135870     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2008.00081     Document Type: Article

References (48)

1. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl JMed 1996;334:1084-9.
2. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998;339:1665-71.
3. Yadav JS, Roubin GS, King P, et al. Angioplasty and stenting for restenosis after carotid endarterectomy. Initial experience. Stroke 1996;27:2075-9.
4. Yadav JS, Roubin GS, Iyer S, et al. Elective stenting of the extracranial carotid arteries. Circulation 1997;95:376-81.
5. Wholey MH, Wholey M, Mathias K, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 2000;50:160-7.
6. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-501.
7. Gray WA, Hopkins LN, Yadav S, et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 2006; 44:258-68.
8. Ringleb PA, Allenberg J, Bruckmann H, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised noninferiority trial. Lancet 2006;368:1239-47.
9. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-71.
10. Furlan AJ. Carotid-artery stenting-case open or closed? N Engl J Med 2006;355:1726-9.
11. Hamon M, Riddell JW. Endarterectomy versus stenting for carotid stenosis. N Engl J Med 2007;356:305-6.
12. Maree AO, Rosenfield KA. Endarterectomy versus stenting for carotid stenosis. N Engl J Med 2007;356:306-7.
13. Bonvini RF, Righini M. Endarterectomy versus stenting for carotid stenosis. N Engl J Med 2007;356:305-7.
14. Groschel K, Ernemann U, Riecker A, et al. Incidence and risk factors for medical complications after carotid artery stenting. J Vasc Surg 2005;42:1101-6.
15. Lam RC, Lin SC, DeRubertis B, et al. The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg 2007;45:875-80.
16. Schluter M, Reimers B, Castriota F, et al. Impact of diabetes, patient age, and gender on the 30-day incidence of stroke and death in patients undergoing carotid artery stenting with embolus protection: a post-hoc subanalysis of a prospective multicenter registry. J Endovasc Ther 2007;14:271-8.
17. Hart JP, Peeters P, Verbist J, et al. Do device characteristics impact outcome in carotid artery stenting? J Vasc Surg 2006;44:725-30.
18. Iyer V, de Donato G, Deloose K, et al. The type of embolic protection does not influence the outcome in carotid artery stenting. J Vasc Surg 2007;46:251-6.
19. Bhatt DL, Kapadia SR, Bajzer CT, et al. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. J Invasive Cardiol 2001;13:767-71.
20. McKevitt FM, Randall MS, Cleveland TJ, et al. The benefits of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc Surg 2005;29:522-7.
21. de Borst GJ, Ackerstaff RG, de Vries JP, et al. Carotid angioplasty and stenting for postendarterectomy stenosis: long-term follow-up. J Vasc Surg 2007;45:118-23.
22. Centre for Evidence-Based Medicine. Levels of evidence. Available at: http://www.cebm.net/levels_of∅idence.asp (accessed October 23, 2007).
23. Dreser H. Archiv fur die Gesamte Physiologie 1899;76:306-18. (transl.) in John C. Krantz, Historical Medical Classics Involving New Drugs. Baltimore: The Williams & Wilkins Co.; 1974.
24. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-5.
25. Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, stroke by prolonged antiplatelet therapy in various categories of patients.: Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106.
26. Patrono C, Coller B, FitzGerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):234S-64S.
27. Bendixen BH, Adams HP. Ticlopidine or clopidogrel as alternatives to aspirin in prevention of ischemic stroke. Eur Neurol 1996;36:256-7.
28. Schafer AI. Antiplatelet therapy. Am J Med 1996;101:199-209.
29. Verstraete M, Zoldhelyi P. Novel antithrombotic drugs in development. Drugs 1995;49:856-84.
30. Mehta SR, Yusuf S, Peters RJG, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
31. Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005;111:2233-40.
32. McKevitt FM, Randall MS, Cleveland TJ, et al. The benefits of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc Surg 2005;29:522-7.
33. Hobson RW, Brott TG, RoubinGS, et al. Closure of the lead-in phase of CREST (Carotid Revascularization Endarterectomy Vs. Stenting Trial): 30-day and one-year analyses. Stroke 2008;39:268-72.
34. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
35. Denninger MH, Necciari J, Serre-Lacroix E, Sissmann J. Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis. Semin Thromb Hemost 1999;25 Suppl 2:41-5.
36. Yadav JS. Management practices in carotid stenting. Cerebrovasc Dis 2001;11 Suppl 2:18-22.
37. McLean J. The discovery of heparin. Circulation 1959;19:75-8.
38. Kakkar VV, Corrigan T, Spindler J, et al. Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial. Lancet 1972;2(7768):101-6.
39. Wholey MH, Wholey MH, Eles G, et al. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther 2003;10:33-41.
40. Hofmann R, Kerschner K, Steinwender C, et al. Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting: a randomized study. Stroke 2002;33:725-7.
41. Shawl FA. Carotid artery stenting: acute and long-term results. Curr Opin Cardiol 2002;17:671-6.
42. Hardman JG, Gilman AG, Limbird LE. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996.
43. Yamamura A, Oyama H, Matsuno F, et al. [Percutaneous transluminal angioplasty for cervical carotid artery stenosis]. No Shinkei Geka 1995;23:117-23.
44. Nano G, Dalainas I, Bianchi P, et al. Ballooning-induced bradycardia during carotid stenting in primary stenosis and restenosis. Neuroradiology 2006;48:533-6.
45. Trocciola SM, Chaer RA, Lin SC, et al. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting. J Vasc Surg 2006;43:714-20.
46. Cayne NS, Faries PL, Trocciola SM, et al. Carotid angioplasty and stent-induced bradycardia and hypotension: impact of prophylactic atropine administration and prior carotid endarterectomy. J Vasc Surg 2005;41:956-61.
47. Groschel K, Ernemann U, Schulz JB, et al. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology 2006;240:145-51.
48. Paraskevas KI, Athyros VG, Briana DD, et al. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets 2007;8:942-51.